NCT02039258View on ClinicalTrials.gov

Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

CANA/MET XR FDC

Canagliflozin/extended release Metformin (CANA/MET XR) fixed dose combination (FDC) tablet of 150 mg/1,000 mg

Trial Locations (1)

Unknown

Lincoln

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02039258 - Pharmacokinetics of a Fixed Dose Combination of Canagliflozin/Metformin Coadministered With Food | Biotech Hunter | Biotech Hunter